IMNN - imunon.com Long-Term Debt Volume

Graphic logo of Imunon (IMNN)

This chart of Imunon, Inc. (IMNN) asset value on the GURU.Markets platform reflects the dynamics of long-term liabilities, which currently stand at 0.01. The company is implementing IT systems for the digital design of genetic drugs, reducing manual labor for scientists. Robotic complexes allow for a manifold increase in the number of weekly tests. However, oncology research costs are creating a financial deficit and increasing the company's market vulnerability.

IMNN Imunon Inc Company Long-Term Liabilities (04/28/2023 - 10/30/2026)

Summary analytical data breakdowns for Imunon (IMNN)

- market price and analyst price targets:
Stock Price Imunon Inc|IMNN - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Imunon|IMNN - Total Company Value
- balance sheet equity data:
Accounting Value per Share Imunon|IMNN - Company Net Assets|Market Capitalization to Book Value Ratio imunon.com|IMNN - Aggregate Company Assets
- debt level and financial liquidity data:
Debt to Equity Ratio Imunon, Inc.|IMNN - Long-Term Debt to Equity|Current Liabilities to Capital Imunon Inc|IMNN - Company Debts|Debt to Book Value Ratio Imunon|IMNN - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Imunon|Interim Coverage Ratio imunon.com
- earnings and multiples data:
IMNN - Company Net Income
Analysis of all company metrics:Imunon, Inc. - IMNN
Flagship merchandise of imunon.com

This indicator measures total liabilities with maturities exceeding one year, reflecting the dependence of cash flows on the cost of servicing borrowed capital. Analyzing the long-term debt of Imunon, Inc. (IMNN) allows for an assessment of the company's financial stability when funding costly developments in DNA cancer immunotherapy, determining the balance between credit leverage and investments in scientific innovation.

Competitor analysis for Imunon, Inc.

Company Long-Term Debts Tempus Labs TEM|Qiagen - Company Long-Term Debts|Long-Term Debt Volume Ionis Pharmaceuticals, Inc. IONS|Repligen Corp. (RGEN) - Company Long-Term Debt|Company Long-Term Liabilities Avidity Corp|Company Long-Term Liabilities CRSP|Company Long-Term Debts genedx.com|Company Long-Term Debt Ultragenyx (RARE)|Beam Therapeutics Inc - Company Long-Term Indebtedness|Company Long-Term Debt Sarepta Therapeutics Inc SRPT|Twist Bioscience Corp (TWST) - Long-Term Debt|TXG - Company Long-Term Debt|NTLA (intelliatx.com) - Company Long-Term Indebtedness|STOK (Stoke Therapeutics, Inc.) - Company Long-Term Liabilities|BioLife Solutions Inc - Company Long-Term Loans and Borrowings|WVE (Wave Life Sciences Corp) - Company Long-Term Debts|Maze Therapeutics Corp (MAZE) - Long-Term Debt Volume|Company Long-Term Debt Sionna Therapeutics Inc (SION)|primemedicine.com - Company Long-Term Indebtedness|Company Long-Term Debts TSHA (Taysha Gene Therapies, Inc.)|QURE - Company Long-Term Liabilities|MGTX: Company Long-Term Liabilities|Long-Term Debt Volume REGENXBIO Corp RGNX|SLDB: Company Long-Term Debts|OCGN - Long-Term Debt Volume|Company Long-Term Debt PacBio|Company Long-Term Liabilities Benitec Biopharma Inc (BNTC)|Company Long-Term Debt Design Pharma (DSGN)|Rocket Corp - Company Long-Term Indebtedness|Company Long-Term Debt 4D Molecular Therapeutics FDMT|LXEO: Company Long-Term Indebtedness|Korro Bio, Inc - Company Long-Term Debts|EDIT (Editas Medicine Inc) - Company Long-Term Indebtedness|Silence Therapeutics Inc. (SLN) - Company Long-Term Debt|Company Long-Term Indebtedness PRQR|CDXS (Codexis Inc) - Company Long-Term Debts|Company Long-Term Debts sangamo.com|Company Long-Term Debts NAUT|Long-Term Debt Volume Metagenomi Inc.|Company Long-Term Debt Precision BioSciences DTIL|GBIO - Company Long-Term Liabilities|BOLD: Company Long-Term Liabilities|XCUR - Company Long-Term Debts|phiopharma.com (PHIO) - Company Long-Term Debt|Company Long-Term Indebtedness MBIO|Company Long-Term Debt TransCode Therapeutics Inc.|Long-Term Debt Bionano BNGO|Company Long-Term Debt Applied DNA Sciences (APDN)|bluebirdbio.com - Company Long-Term Indebtedness|ImmunoPrecise Antibodies Ltd. - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings OMGA|Singular Genomics Systems Inc - Company Long-Term Debts|Long-Term Debt Volume Regulus RGLS|Syros Pharmaceuticals (SYRS) - Company Long-Term Debt|Company Long-Term Indebtedness TBIO|TCON (TRACON Pharmaceuticals, Inc.) - Company Long-Term Debts|Company Long-Term Liabilities Unity Biotechnology Inc. (UBX)